Marker Therapeutics to Participate in Cantor Fitzgerald Cell and Genetic Medicines Conference Sep 8, 2022 07:00AM
Marker Therapeutics to Present at Three Upcoming September Investor Conferences Sep 7, 2021 04:05PM
Cantor Fitzgerald Starts Marker Therapeutics (MRKR) at Overweight Mar 18, 2021 04:03PM
Marker Therapeutics, Inc. Announces Closing of Public Offering of Common Stock Mar 16, 2021 04:57PM
Marker Therapeutics (MRKR) Prices 28.572M Share Common Offering at $1.75/Sh Mar 12, 2021 08:02AM


Mar 12, 2021 08:00AM Marker Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock